Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells-Reference-Cited by-同舟云学术

Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells

Published:2012-09 Issue:1 Volume:322 Page:113-118
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Bliesath Joshua,Huser Nanni,Omori Mayuko,Bunag Daniel,Proffitt Chris,Streiner Nicole,Ho Caroline,Siddiqui-Jain Adam,O’Brien Sean E.,Lim John K.C.,Ryckman David M.,Anderes Kenna,Rice William G.,Drygin Denis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005

2. Untangling the ErbB signalling network;Yarden;Nat. Rev. Mol. Cell Biol.,2001

3. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines;Engelman;Proc. Natl. Acad. Sci. USA,2005

4. Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity;Buck;Mol. Cancer Ther.,2006

5. Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors;Buck;Mol. Cancer Ther.,2006

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase CK2: An emerging regulator of cellular metabolism;BioFactors;2023-12-29

2. Preclinical Characterization of 22-(4′-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis via AKT/mTOR Signaling;ACS Pharmacology & Translational Science;2023-07-25

3. Catalyst-free direct synthesis of indeno[1,2-b]indol-5(4bH)-yl benzimidamides;Zeitschrift für Naturforschung B;2023-03-13

4. Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects;Journal of Medicinal Chemistry;2023-02-06

5. CK2 and the Hallmarks of Cancer;Biomedicines;2022-08-16